Tenpoint’s aim is to reverse vision loss by generating specialized ocular cell types, both ex vivo and in vivo.
Hattie Hayes
Advertisement
Articles by Hattie Hayes
Margaret Chang, MD, MS, spoke with Modern Retina to give an update on avacincaptad pegol for geographic atrophy.
Advertisement
Advertisement
Advertisement
Trending on Modern Retina
1
The gene therapy shift: A closer look at the science powering next-generation retinal treatments
2
Understanding fluid fluctuation in retinal disorders
3
Inflammasome Therapeutics completes phase 2 trial enrollment for K8 in GA
4
Evaluating Progressive Multifocal Geographic Atrophy in an Asymptomatic 81-Year-Old Male
5
